“showed a trend”

The available data showed a trend ( p = 0.06) of somewhat lower BMI in AD pools (24.9 ± 1.4 kg/m 2 ) than HC pools (26.5 ± 1.1 kg/m 2 ).

PD showed a trend that was not significant ( p = 0.06) and no differences were observed in FAZa or FAZp. 3.3.

Results Table 1 presents the Bamford–Kowal–Bench sentence test results for the five people entered into the study. One-way repeated-measures ANOVA indicated that different PPE equipment scenarios did not significantly alter Bamford–Kowal–Bench sentence test results in office or emergency department settings ( p = 0.26 and p = 0.58 respectively), but showed a trend in intensive care unit settings ( p = 0.06).

Lower Glasgow Coma Scale showed a trend ( P = 0.06) as an independent predictor of ≥6‐mL growth but was an independent predictor of ICrH Expansion Scale change.

The analysis of demyelinated layers I/II showed a trend toward higher numbers of NogoA + cells in patients with early versus late MS ( p = 0.06).

Multivariable analysis demonstrated that IABP use was independently associated with a lower risk of pulmonary edema (OR 0.4; 95% CI 0.2–0.7; P=0.001) and showed a trend toward reduced mortality (OR 0.54; 95% CI 0.29–1.01; P=0.06). 51 Furthermore, a meta-analysis of 22 observational studies involving 4,653 adult cardiogenic shock patients treated with VA-ECMO assessed the effect of concomitant IABP on short-term mortality.

Notably, GGT showed a trend favoring SGLT2i with a borderline p-value ( P = 0.06 in the anti-diabetic drug subgroup), while FBG reduction lacked statistical significance.

Hypertension without heart disease showed a trend towards increased risk with delayed surgery (HR = 2.05, p = 0.06), but this did not reach statistical significance, as shown in Table 7 .

For DFS, age showed a trend toward poorer outcomes (HR = 2.10; 95% CI: 0.99–4.46; p = 0.06).

Low-dose tofacitinib significantly extended survival of ALS mice compared to untreated control ALS mice in the intervention (6.2 day increase; p = 0.02) and cycle (7.3 day increase, p = 0.004) regimens and showed a trend towards improvement in the prevention regimen (p = 0.06; Figure 1B ).

In the multivariable logistic regression analysis with the stepwise forward selection approach, the diagnosis of VEXAS syndrome was significantly associated with the age at disease onset (OR: 1.13, 95% CI: 1.02–1.30, p = 0.04) and the presence of lymphadenopathy (OR: 67.49, 95% CI: 5.36–3284.89, p = 0.007), while thrombocytopenia showed a trend toward statistical significance (OR: 12.02, 95% CI: 1.07–315.86, p = 0.06).

[ 17 ] showed a trend toward decreased lymph node metastasis for sessile nonpedunculated tumors compared with nonpolypoid, exophytic or ulcerated lesions ( P = 0.06) in pT1 and pT2 rectal cancers.

In contrast, mice receiving BTS at 300 mg/kg showed a trend towards increased total distance traveled ( Figure 2C , p = 0.06) compared to HFD mice.

While bloodletting showed a trend toward greater improvement than drug therapy, the difference was nonsignificant (MD = −0.04; 95% CI: [−0.08, 0.00]; p = 0.06; Figure 14 ), with no heterogeneity ( I 2 = 0%, p = 0.94). 3.10.

Specifically, D14 diversity differed from D1 (ANOVA, p=0.038) and showed a trend towards a decrease compared to D7 (ANOVA, p=0.06; Figure 5A ).

Subgroup analyses showed a trend toward efficacy for the RCT (lumateperone) on response rate (RR = 1.32, p = 0.06), while post-hoc analyses demonstrated significant benefit (RR = 1.35, p < 0.001; Supplementary Figure 11 ).

The same analysis performed after exclusion of EMCS patients showed a trend of an effect ( p = 0.06).

Although the resistance model showed a trend toward worse PFS (HR = 2.3, P = 0.06), significance was not reached.

Additionally, only O increased MAFBx and RPS26 60–90 min after the first exercise bout in T legs compared to UT ( P < 0.05) and showed a trend for increase with MuRF‐1 ( P = 0.06).

Kruskal–Wallis tests used to investigate if total testosterone values, PSA values, SDS height change from previous evaluation, growth rate, growth in BTV, increase in penile length, were associated with a specific weekly dosage of gonadotropins (and specifically to hCG) found that: (1) as expected T levels were strictly associated with the weekly dosage of hCG ( p < 0.0001); (2) PSA also showed a trend to significance in the association with the weekly dosage of hCG ( p = 0.06); (3) the administration of hCG, but not the dosage used, was found to be associated with a significant increment of height ( p = 0.001); (4) the administration of hCG, but not the dosage used, was found to be associated to a significant increment of BTV ( p = 0.002) and penile length ( p = 0.007) after 6 months.

The use of veteran transportation services showed a trend to decrease the rates of no-shows without reaching statistical significance (7% vs. 14.5%, p = 0.06).

In patients aged over 70, the predictive ability of the FIB‐3 index for 5‐year OS showed a trend toward superiority ( p = 0.06), whereas the predictive performance for RFS was nearly identical between the two indices (Figure 5B,F ).

Cirrhotic patients showed a trend toward increased perioperative transfusion (19% vs. 0%, p = 0.06) and postoperative ICU admission (28.6% vs. 11.8%, p = 0.21).

Increases in CBV from baseline to peak plantar flexion exercise after BR placebo and BR nitrate showed a trend for a greater increase in CBV at the peak workload of plantar flexion with BR nitrate ( p = 0.06; Cohen’s d = 0.56).

The comparison of cluster 1 and cluster 3 did not reach significance, but showed a trend towards higher frailty scores in cluster 1 (1 - 3: p = 0.06).